Publication Name	World Journal of Experimental Medicine
Manuscript ID	88541
Country	Iraq

Received	2023-09-27 16:34
Peer-Review Started	2023-09-27 16:34
To Make the First Decision
Return for Revision	2024-01-02 09:38
Revised	2024-01-08 15:18
Second Decision	2024-02-02 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-02-02 07:11
Articles in Press	2024-02-02 07:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-03-12 00:34
Publish the Manuscript Online	2024-03-19 14:54

ISSN	2220-315x (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Health Care Sciences & Services
Manuscript Type	Clinical Trials Study
Article Title	Impact of primary percutaneous coronary intervention on ST-segment elevation myocardial infarction patients: A comprehensive analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Eza Nawzad Saeed and Abdlsatar Kamal Faeq
Funding Agency and Grant Number
Corresponding Author	Eza Nawzad Saeed, MBChB, Researcher, Department of Medicine, Hawler Medical University, Erbil - IRAQ , Erbil 44001, Kurdistan, Iraq. demolali542@gmail.com
Key Words	Percutaneous coronary intervention; Impact analysis, Segment Elevation, Erbil
Core Tip	Myocardial infarction, particularly the ST-segment elevation myocardial infarction (STEMI) subtype, is a leading global cause of mortality. Primary percutaneous coronary intervention is the preferred treatment, but its success depends on various factors. In a study of 96 consecutive STEMI patients at Erbil Cardiac Center, factors predicting in-hospital mortality included atypical presentation, cardiogenic shock, chronic kidney disease, (TIMI) grades 0/1/2, triple vessel disease, ventricular tachycardia/ventricular fibrillation, coronary dissection, and no-reflow phenomenon. Significantly, the time from symptom onset to hospital arrival emerged as a critical determinant in improving STEMI prognosis.
Publish Date	2024-03-19 14:54
Citation	Saeed EN, Faeq AK. Impact of primary percutaneous coronary intervention on ST-segment elevation myocardial infarction patients: A comprehensive analysis. World J Exp Med 2024; 14(1): 88541
URL	https://www.wjgnet.com/2220-315x/full/v14/i1/88541.htm
DOI	https://dx.doi.org/10.5493/wjem.v14.i1.88541

Full Article (PDF)	WJEM-14-88541-with-cover.pdf
CONSORT 2010 Statement	88541-CONSORT 2010 statement.pdf
Manuscript File	88541_Auto_Edited-LJH-YJP.docx
Answering Reviewers	88541-Answering reviewers.pdf
Audio Core Tip	88541-Audio core tip.m4a
Biostatistics Review Certificate	88541-Biostatistics statement.pdf
Clinical Trial Registration Statement	88541-Clinical trial registration statement.pdf
Conflict-of-Interest Disclosure Form	88541-Conflict-of-interest statement.pdf
Copyright License Agreement	88541-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	88541-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	88541-Institutional review board statement.pdf
Peer-review Report	88541-Peer-review(s).pdf
Scientific Misconduct Check	88541-Bing-Liu JH-2.png
Scientific Misconduct Check	88541-CrossCheck.png
Scientific Editor Work List	88541-Scientific editor work list.pdf
CrossCheck Report	88541-CrossCheck report.pdf